NEW YORK (GenomeWeb News) – Applied Biosystems, a business of Life Technologies, announced today that has formed a strategic alliance with the Translational Genomics Research Institute.

Under the agreement, a team of researchers from TGen and Applied Biosystems will use Applied Biosystems' SOLiD 3 system to do genomic analyses of thousands of patient samples. The goal is to increase researchers' understanding of the genetics behind various complex diseases and medical conditions and hasten the translation of such research into new diagnostic and other clinical tools.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.